metadata toggle
Qualitative and quantitative composition
Each dose of 1 ml contains:
Active substances:
Lyophilisate (live attenuated):
Minimum
Maximum
Canine distemper virus, strain CDV Bio 11/A
103.1 TCID50*
105.1 TCID50*
Canine adenovirus Type 2, strain CAV-2
Bio 13
103.6 TCID50*
105.3 TCID50*
Canine parvovirus Type 2b, strain CPV-2b
Bio 12/B
104.3 TCID50*
106.6 TCID50*
Canine parainfluenza Type 2 virus, strain CPiV-2
Bio 15
103.1 TCID50*
105.1 TCID50*
Suspension (inactivated):
Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae strain MSLB 1089
ALR** titre ≥ 1:51
Leptospira interrogans serogroup Canicola serovar Canicola,
strain MSLB 1090
ALR** titre ≥ 1:51
Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa, strain MSLB 1091
ALR** titre ≥ 1:40
Leptospira interrogans serogroup Australis serovar Bratislava,
strain MSLB 1088
ALR** titre ≥ 1:51
* Tissue culture infectious dose 50%.
** Antibody micro agglutination-lytic reaction.
Adjuvant:
Aluminium hydroxide
1.8–2.2 mg.
Excipients:
Qualitative composition of excipients and other constituents
Lyophilisate:
Trometamol
Edetic Acid
Sucrose
Dextran 70
Suspension:
Sodium chloride
Potassium chloride
Potassium dihydrogen phosphate
Disodium phosphate dodecahydrate
Water for injections
The visual appearance is as follows:
Lyophilisate: spongy matter of white colour.
Suspension: whitish colour with fine sediment.